Because the diagnostic term “glioblastoma” now refers to adult-type isocitrate dehydrogenase (IDH) and H3-wildtype diffuse high-grade gliomas, it is no longer recommended terminology in pediatric patients. This evidence concerns the gene IDH2 and central nervous system cancer.